MIT spinout Strand Therapeutics has developed a new class of mRNA molecules that can sense where they are in the body, for more targeted and powerful treatments.
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.
During 18 years of leadership, Evans established new R&D mission areas, strengthened ties to the MIT community, and increased inclusion and education efforts.
MIT AgeLab annual awards go to high school students who lead or develop intergenerational programs, bringing together younger and older people in their communities.